Herbalife (HLF) Competitors $9.74 -0.14 (-1.37%) Closing price 07/25/2025 03:59 PM EasternExtended Trading$9.79 +0.04 (+0.46%) As of 07/25/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HLF vs. PBH, USNA, NUS, NATR, MED, VERU, EL, IPAR, WBA, and AAPShould you be buying Herbalife stock or one of its competitors? The main competitors of Herbalife include Prestige Consumer Healthcare (PBH), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estee Lauder Companies (EL), Interparfums (IPAR), Walgreens Boots Alliance (WBA), and Advance Auto Parts (AAP). Herbalife vs. Its Competitors Prestige Consumer Healthcare USANA Health Sciences Nu Skin Enterprises Nature's Sunshine Products Medifast Veru Estee Lauder Companies Interparfums Walgreens Boots Alliance Advance Auto Parts Prestige Consumer Healthcare (NYSE:PBH) and Herbalife (NYSE:HLF) are both personal products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations. Which has more risk and volatility, PBH or HLF? Prestige Consumer Healthcare has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. Comparatively, Herbalife has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500. Is PBH or HLF more profitable? Prestige Consumer Healthcare has a net margin of 18.86% compared to Herbalife's net margin of 5.66%. Prestige Consumer Healthcare's return on equity of 12.87% beat Herbalife's return on equity.Company Net Margins Return on Equity Return on Assets Prestige Consumer Healthcare18.86% 12.87% 6.78% Herbalife 5.66%-23.75%7.86% Do analysts recommend PBH or HLF? Prestige Consumer Healthcare currently has a consensus target price of $93.33, indicating a potential upside of 21.58%. Herbalife has a consensus target price of $11.50, indicating a potential upside of 18.01%. Given Prestige Consumer Healthcare's higher probable upside, research analysts plainly believe Prestige Consumer Healthcare is more favorable than Herbalife.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prestige Consumer Healthcare 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Herbalife 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media prefer PBH or HLF? In the previous week, Prestige Consumer Healthcare and Prestige Consumer Healthcare both had 3 articles in the media. Prestige Consumer Healthcare's average media sentiment score of 1.26 beat Herbalife's score of 1.16 indicating that Prestige Consumer Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prestige Consumer Healthcare 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Herbalife 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, PBH or HLF? Herbalife has higher revenue and earnings than Prestige Consumer Healthcare. Herbalife is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrestige Consumer Healthcare$1.14B3.33$214.60M$4.2917.90Herbalife$4.99B0.20$254.30M$2.743.56 Do insiders & institutionals believe in PBH or HLF? 100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. 1.4% of Prestige Consumer Healthcare shares are owned by company insiders. Comparatively, 1.7% of Herbalife shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryPrestige Consumer Healthcare beats Herbalife on 8 of the 14 factors compared between the two stocks. Get Herbalife News Delivered to You Automatically Sign up to receive the latest news and ratings for HLF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HLF vs. The Competition Export to ExcelMetricHerbalifeRETAIL IndustryRetail SectorNYSE ExchangeMarket Cap$1.01B$5.52B$26.96B$21.10BDividend YieldN/AN/A177.03%3.59%P/E Ratio3.563.5630.7428.44Price / Sales0.200.136.4858.59Price / Cash3.112.5752.3122.92Price / Book-1.231.395.694.69Net Income$254.30M-$4.19B$880.44M$995.51M7 Day Performance5.12%3.08%2.33%1.65%1 Month Performance16.96%9.49%7.10%4.54%1 Year Performance-22.04%-11.91%25.92%9.99% Herbalife Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HLFHerbalife4.3079 of 5 stars$9.75-1.4%$11.50+18.0%-17.6%$1.01B$4.99B3.568,600Positive NewsPBHPrestige Consumer Healthcare3.8922 of 5 stars$75.65-0.2%$93.33+23.4%+9.1%$3.74B$1.14B17.63540Positive NewsUSNAUSANA Health Sciences4.561 of 5 stars$30.28-0.2%$36.00+18.9%-23.6%$563.72M$854.50M16.631,700Trending NewsEarnings ReportAnalyst RevisionNUSNu Skin Enterprises2.8901 of 5 stars$8.56+2.6%$6.88-19.7%-15.9%$422.80M$1.73B-10.703,100NATRNature's Sunshine Products2.2377 of 5 stars$14.80-0.5%$18.33+23.9%-12.0%$273.21M$454.36M27.92850Positive NewsUpcoming EarningsMEDMedifast3.1197 of 5 stars$13.80+4.2%$16.50+19.6%-23.8%$151.66M$602.46M-21.23870VERUVeru2.5215 of 5 stars$0.58-2.8%$4.00+589.7%-40.8%$85.02M$16.89M-2.42230ELEstee Lauder Companies3.9036 of 5 stars$86.13-1.2%$82.50-4.2%-9.6%$30.98B$15.61B-35.5962,000Positive NewsAnalyst UpgradeGap UpIPARInterparfums4.6804 of 5 stars$129.10-0.3%$162.00+25.5%-11.0%$4.15B$1.45B25.12530News CoveragePositive NewsWBAWalgreens Boots Alliance2.2836 of 5 stars$11.52+0.3%$10.59-8.1%+0.9%$9.97B$147.66B-1.58312,000Positive NewsAAPAdvance Auto Parts2.8859 of 5 stars$62.82+2.8%$46.53-25.9%-2.5%$3.76B$9.09B-10.7062,800Trending NewsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies PBH Alternatives USNA Alternatives NUS Alternatives NATR Alternatives MED Alternatives VERU Alternatives EL Alternatives IPAR Alternatives WBA Alternatives AAP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HLF) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Herbalife Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Herbalife With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
